AstraZeneca to invest in new Covid-19 vaccine production in Eastern Germany
10th Feb 2021 16:03
(Sharecast News) - AstraZeneca may partner with Germany's IDT Biologika to produce its Covid-19 vaccine in a bid to bolster supplies.
Read moreWednesday broker round-up
10th Feb 2021 13:12
(Sharecast News) - Ocado Group: Berenberg reiterates buy with a target price of 2,925p.
Read moreWHO claims animals 'most likely' origin of SARS-CoV-2
9th Feb 2021 11:55
(Sharecast News) - World Health Organization scientists who have been studying the origin of the Covid-19 virus in China over the past four weeks concluded that the most likely origin of the illness was in animals.
Read more'Jury still out' on whether world needs new Covid-19 vaccines, Oxford's Pollard says
9th Feb 2021 09:29
(Sharecast News) - It remains to be seen whether the world needs new vaccines to fend off the new strains of novel coronavirus, a top researcher said.
Read moreAstraZeneca vaccine protects against severe Covid-19 from SA variant, ShoreCap says
9th Feb 2021 09:15
(Sharecast News) - The novel coronavirus vaccine developed by AstraZeneca and the University of Oxford is likely effective in preventing severe cases of Covid-19, or those requiring hospitalisation, analysts at Shore Capital said.
Read moreSouth Africa halts AstraZeneca vaccinations after weak results against local variant
8th Feb 2021 12:34
(Sharecast News) - South Africa halted its rollout of AstraZeneca's Covid-19 vaccine after a study claimed that it offered "minimal protection" against mild to moderate disease from the local variant of the novel coronavirus.
Read moreSunday newspaper round-up: AstraZeneca, Amazon, Retailers
7th Feb 2021 11:55
(Sharecast News) - Vaccines Minister Nadhim Zahawi today said AstraZeneca is 'confident' its jab prevents serious illness caused by the South African coronavirus variant after early data from a small study suggested the vaccine was less effective against the strain. Mr Zahawi said he had spoken to England's Deputy Chief Medical Officer Jonathan Van Tam this morning about the study as he insisted the vaccine 'does protect against severe disease'. He said that through its own trials AstraZeneca is 'confident that it does effectively deal with serious illness, serious disease and hospitalisation'. - Financial Mail on Sunday
Read moreUK watchdog confirms continued 'high' safety of Covid-19 vaccines
5th Feb 2021 12:56
(Sharecast News) - Ongoing safety checks by the UK regulator confirmed the safety of Covid-19 vaccines.
Read moreAstraZeneca's Imfinzi fails to meet endpoint in cancer trial
5th Feb 2021 08:05
(Sharecast News) - AstraZeneca said on Friday that its Imfinzi (durvalumab) drug failed to meet its primary endpoint in a Phase III trial for head and neck cancers.
Read moreUK launches trial combining different Covid vaccines
4th Feb 2021 11:27
(Sharecast News) - The UK has launched the first trial in the world that explores mixing different Covid-19 vaccines for the first and second jab.
Read moreAstraZeneca secures Forxiga approval in China
4th Feb 2021 08:00
(Sharecast News) - AstraZeneca announced on Thursday that 'Forxiga', or dapagliflozin, has been approved in China to reduce the risk of cardiovascular death and hospitalisation for heart failure, in adults with heart failure (NYHA class II-IV) with reduced ejection fraction.
Read moreAstraZeneca Covid-19 vaccine 82% effective, reduces transmission by two thirds
2nd Feb 2021 18:52
(Sharecast News) - Spacing out the doses of AstraZeneca's Covid-19 vaccine by three months raises their effectiveness to 82%, the results of a new study revealed.
Read moreAstraZeneca to divest Viela Bio stake
1st Feb 2021 13:01
(Sharecast News) - AstraZeneca has agreed to divest its 26.7% stake in US biotechnology company Viela Bio as part of the latter's proposed acquisition by Horizon Therapeutics.
Read moreAstraZeneca pledges 9m more Covid vaccine jabs to EU
1st Feb 2021 07:34
(Sharecast News) - AstraZeneca is set to supply an extra nine million doses of its Covid-19 vaccine to the European Union after a high-profile row over shortages.
Read moreSunday newspaper round-up: Vaccine supplies, Debenhams, The Queen
31st Jan 2021 21:49
(Sharecast News) - The UK could help the EU and other nations with coronavirus vaccine supplies even before the domestic vaccination programme has been completed, the international trade secretary, Liz Truss, has said. As ministers sought to smooth relations with Brussels after the EU's much-criticised and swiftly rescinded decision to impose a vaccine border between Northern Ireland and the Republic of Ireland, Truss sought to stress the need for international cooperation. - Guardian
Read more